Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
Sponsor: Sirtsei Pharmaceuticals, Inc.
Summary
This is a Phase 2B clinical study evaluating the effectiveness and safety of SP-624 as compared to placebo in the treatment of adults with Major Depressive Disorder.
Official title: A Multi-center, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
456
Start Date
2024-03-25
Completion Date
2026-07-01
Last Updated
2026-04-01
Healthy Volunteers
No
Conditions
Interventions
SP-624
Once daily oral administration of two capsules totaling 20 mg/day
Placebo
Once daily oral administration of two matching placebo capsules
Locations (50)
IMA Clinical Research
Phoenix, Arizona, United States
Noble Clinical Research
Tucson, Arizona, United States
SanRo Clinical Research Group
Bryant, Arkansas, United States
Clinical Innovations
Bellflower, California, United States
Sun Valley Research Center
Imperial, California, United States
Synergy San Diego
Lemon Grove, California, United States
Excell Research
Oceanside, California, United States
CiTrials
Riverside, California, United States
Collaborative Neuroscience Research
Torrance, California, United States
Sunwise Clinical Research
Walnut Creek, California, United States
Next Level Clinical Trials
West Covina, California, United States
MCB Clinical Research Centers
Colorado Springs, Colorado, United States
Clinical Neuroscience Solutions
Jacksonville, Florida, United States
Accel Clinical
Lakeland, Florida, United States
Segal Trials
Lauderhill, Florida, United States
Segal Trials - Miami Lakes
Miami Lakes, Florida, United States
Clinical Neuroscience Solutions
Orlando, Florida, United States
DMI Research
Pinellas Park, Florida, United States
Accelerated Enrollment Solutions
Atlanta, Georgia, United States
Velocity Clinical Research
Meridian, Idaho, United States
Revive Research Institute
Elgin, Illinois, United States
Tandem Clinical Research
Marrero, Louisiana, United States
Boston Clinical Trials
Boston, Massachusetts, United States
Neurobehavioral Medicine Group
Bloomfield Hills, Michigan, United States
Midwest Research Group
Saint Charles, Missouri, United States
Alivation Research
Lincoln, Nebraska, United States
IMA Clinical Research
Las Vegas, Nevada, United States
Redbird Research
Las Vegas, Nevada, United States
Center for Emotional Fitness
Cherry Hill, New Jersey, United States
CenExel HRI
Marlton, New Jersey, United States
IMA Clinical Research
Albuquerque, New Mexico, United States
Integrative Clinical Trials
Brooklyn, New York, United States
Pioneer Clinical Research
New York, New York, United States
Magnolia Clinical Research
Cary, North Carolina, United States
UNC Chapel Hill
Chapel Hill, North Carolina, United States
New Hope Clinical Research
Charlotte, North Carolina, United States
Velocity Clinical Research
Beachwood, Ohio, United States
Midwest Clinical Research Center
Dayton, Ohio, United States
North Star Medical Research
Middleburg Heights, Ohio, United States
Summit Headlands
Portland, Oregon, United States
Coastal Carolina Research Center
North Charleston, South Carolina, United States
Clinical Neuroscience Solutions
Memphis, Tennessee, United States
Donald J. Garcia, Jr, MD, PA
Austin, Texas, United States
Future Search Trials of Dallas
Dallas, Texas, United States
Haracec Clinical Research
El Paso, Texas, United States
Pillar Clinical Research
Richardson, Texas, United States
R and H Clinical Research
Stafford, Texas, United States
Grayline Research Center
Wichita Falls, Texas, United States
Northwest Clinical Research Center
Bellevue, Washington, United States
Core Clinical Research
Everett, Washington, United States